Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision
- PMID: 1592998
- DOI: 10.1111/j.1524-4725.1992.tb03307.x
Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision
Abstract
This is the third report in a series that reviews the experience in the Skin and Cancer Unit, from 1955 through 1982, with the treatment of basal cell carcinomas (BCCs). It concerns 588 previously untreated (primary) BCCs removed by surgical excision. The cumulative 5-year recurrence rate was 4.8%. This is a statistically significant lower recurrence rate (P = .034) than 135 previously treated BCCs that had a re-recurrence rate of 11.6%. For the primary BCCs, multivariate analysis showed that location on the head (P = .010) and being male (P = .004) were independent risk factors for recurrence. The patient's age, the duration of the BCC, its maximum diameter, or the time span (1955-1963, 1964-1972, 1973-1982) in which it was treated did not significantly affect the recurrence rate. The 5-year recurrence rate for BCCs excised from various anatomic sites were as follows: 1) neck, trunk, and extremities = 0.7%; 2) head--less than 6 mm in diameter = 3.2%; 3) head--6 to 9 mm in diameter = 8.0% (treated since 1964 = 5.2%); and 4) head--10 mm or more in diameter = 9.0%. Surgical excision is a highly effective method for removal of BCCs, and achieved a good to excellent cosmetic outcome in about 85% of the recurrence-free treatment sites.
Comment in
-
Recurrence rates of treated basal cell carcinomas.J Dermatol Surg Oncol. 1993 Feb;19(2):175-6. doi: 10.1111/j.1524-4725.1993.tb03456.x. J Dermatol Surg Oncol. 1993. PMID: 8429152 No abstract available.
Similar articles
-
Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.J Dermatol Surg Oncol. 1991 Sep;17(9):720-6. doi: 10.1111/j.1524-4725.1991.tb03425.x. J Dermatol Surg Oncol. 1991. PMID: 1820764
-
Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy.J Dermatol Surg Oncol. 1992 Jul;18(7):549-54. doi: 10.1111/j.1524-4725.1992.tb03508.x. J Dermatol Surg Oncol. 1992. PMID: 1624628
-
Recurrence rates of treated basal cell carcinomas. Part 1: Overview.J Dermatol Surg Oncol. 1991 Sep;17(9):713-8. doi: 10.1111/j.1524-4725.1991.tb03424.x. J Dermatol Surg Oncol. 1991. PMID: 1890243
-
Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions.Br J Dermatol. 2004 Sep;151(3):623-6. doi: 10.1111/j.1365-2133.2004.06135.x. Br J Dermatol. 2004. PMID: 15377349 Review.
-
Basal cell carcinoma in Queensland.Aust N Z J Surg. 1981 Dec;51(6):576-90. doi: 10.1111/j.1445-2197.1981.tb05258.x. Aust N Z J Surg. 1981. PMID: 7036977 Review.
Cited by
-
Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management.Yale J Biol Med. 2015 Jun 1;88(2):167-79. eCollection 2015 Jun. Yale J Biol Med. 2015. PMID: 26029015 Free PMC article. Review.
-
Incompletely excised basal cell carcinomas: Our guidelines.Onco Targets Ther. 2008 Jul 1;1:1-4. doi: 10.2147/ott.s3540. Onco Targets Ther. 2008. PMID: 21127747 Free PMC article.
-
Sun-Exposed versus Sun-Protected Cutaneous Basal Cell Carcinoma: Clinico-Pathological Profile and p16 Immunostaining.Diagnostics (Basel). 2023 Mar 28;13(7):1271. doi: 10.3390/diagnostics13071271. Diagnostics (Basel). 2023. PMID: 37046490 Free PMC article.
-
A Review of Black Salve: Cancer Specificity, Cure, and Cosmesis.Evid Based Complement Alternat Med. 2017;2017:9184034. doi: 10.1155/2017/9184034. Epub 2017 Jan 26. Evid Based Complement Alternat Med. 2017. PMID: 28246541 Free PMC article. Review.
-
Challenges and new horizons in the management of advanced basal cell carcinoma: a UK perspective.Br J Cancer. 2014 Oct 14;111(8):1476-81. doi: 10.1038/bjc.2014.270. Epub 2014 Sep 11. Br J Cancer. 2014. PMID: 25211660 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical